Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitionsnews2025-12-11T12:12:44+00:00December 11th, 2025|Endpoints News|
Weight loss biotech Prolynx gets $70M, snags Amgen’s obesity commercial leader as CEOnews2025-12-11T12:00:12+00:00December 11th, 2025|Endpoints News|
Endpoints 100 survey 2025: Biotech CEOs are feeling more upbeatnews2025-12-11T12:00:03+00:00December 11th, 2025|Endpoints News|
Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reportednews2025-12-11T11:45:15+00:00December 11th, 2025|Endpoints News|
House backs Biosecure Act aimed at Chinese companiesnews2025-12-11T09:52:38+00:00December 11th, 2025|Endpoints News|
Investors buy up stocks in biggest follow-on offering day in biotech historynews2025-12-10T19:50:58+00:00December 10th, 2025|Endpoints News|
Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backernews2025-12-10T19:21:12+00:00December 10th, 2025|Endpoints News|
USAntibiotics scores sped-up approval for amoxicillinnews2025-12-10T19:11:01+00:00December 10th, 2025|Endpoints News|
Adare Pharma shutters Philadelphia site and lays off over 100 staffersnews2025-12-10T16:39:05+00:00December 10th, 2025|Endpoints News|
In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
